KR20190016688A - Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same - Google Patents
Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same Download PDFInfo
- Publication number
- KR20190016688A KR20190016688A KR1020170100925A KR20170100925A KR20190016688A KR 20190016688 A KR20190016688 A KR 20190016688A KR 1020170100925 A KR1020170100925 A KR 1020170100925A KR 20170100925 A KR20170100925 A KR 20170100925A KR 20190016688 A KR20190016688 A KR 20190016688A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- salt
- parts
- jade
- powder
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 9
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title description 7
- 230000006872 improvement Effects 0.000 title description 6
- 230000002265 prevention Effects 0.000 title description 2
- 150000003839 salts Chemical class 0.000 claims abstract description 71
- 239000010977 jade Substances 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000843 powder Substances 0.000 claims abstract description 27
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 12
- 239000011707 mineral Substances 0.000 claims abstract description 12
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 238000001704 evaporation Methods 0.000 claims abstract description 9
- 238000010298 pulverizing process Methods 0.000 claims abstract description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 24
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 239000003513 alkali Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 230000032683 aging Effects 0.000 claims description 9
- 229910001566 austenite Inorganic materials 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000010779 crude oil Substances 0.000 claims description 4
- 235000021374 legumes Nutrition 0.000 claims description 4
- 241000332371 Abutilon x hybridum Species 0.000 claims description 3
- 240000002234 Allium sativum Species 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 241000257303 Hymenoptera Species 0.000 claims description 3
- 235000004611 garlic Nutrition 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 66
- 235000010755 mineral Nutrition 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 208000000689 peptic esophagitis Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000008247 solid mixture Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000003673 groundwater Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IFPMZBBHBZQTOV-UHFFFAOYSA-N 1,3,5-trinitro-2-(2,4,6-trinitrophenyl)-4-[2,4,6-trinitro-3-(2,4,6-trinitrophenyl)phenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C=2C(=C(C=3C(=CC(=CC=3[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=CC=2[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)=C1[N+]([O-])=O IFPMZBBHBZQTOV-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017807 Gastric mucosal hypertrophy Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- -1 salt salt Chemical class 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001363 water suppression through gradient tailored excitation Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 옥소금 및 그의 제조방법에 관한 것이다. The present invention relates to jade salts and processes for their preparation.
소금은 인체에 꼭 필요한 물질로서, 음식 제조시에 조미료로 쓰이는 것 이외에 신진대사 촉진, 소화 촉진, 미네랄 공급 등의 효능도 제공한다. 이러한 소금은 크게 천일염 및 정제염으로 나눌 수 있다.Salt is a substance that is essential for human body. It is not only used as a seasoning in food production, but also promotes metabolism, promotes digestion and supplies minerals. These salts can be roughly divided into sun salt and refined salt.
이 중에서 더 좋은 소금은 천일염이라 할 수 있는데, 천일염은 갯벌에 바닷물을 가두어 자연 증발시킨 것으로 햇빛, 바닷물, 갯벌 및 염전 중 한 가지만 빠져도 천일염이 만들어지지 않는다.Among them, the better salt is sun-dried salt, and the sun-dried salt is trapped in the tidal flats and is naturally evaporated. Even if one of sunlight, seawater, tidal-flat, and salt is extinguished,
보통 낮과 밤의 일교차가 크지 않은 5월에서 8월 사이에 생산되는 소금이 염도가 강하면서 쓴맛이 나지 않아 식용으로 가장 적당하다.Salt produced between May and August, which is usually not much difference between day and night, is most suitable for edible because saltiness is strong and bitter taste does not occur.
한국의 천일염전은 대개 저수지, 증발지 및 결정지로 이루어져 있으며, 만조 때 수문을 열어 증발지에서 농축된 염수를 만들고 결정지로 보내 소금 결정을 얻는다. 바람이 심하면 결정이 작고 기온이 낮으면 쓴맛이 나 소금의 질이 떨어지므로 일조량이 많고 바람이 적은 날을 택해 소금을 얻는 것이 좋다.In Korea, the sea salt erosion is mainly composed of reservoir, evaporation and deciduous ground. It opens the water gate at high tide and creates concentrated salt water from the evaporation ground and sends salt crystals to the crystal ground. If the wind is heavy and the crystal is small, and the temperature is low, the bitter taste or the quality of the salt will be lowered. It is better to pick the salt with a lot of sunshine and low wind.
우리나라에서 생산되는 천일염은 알칼리성이며, 염도는 약 88 % 정도이다.The salt produced in Korea is alkaline and the salinity is about 88%.
정제염은 우리가 흔히 먹는 소금으로, 천일염과 정제염의 차이는 천연조미료와 화학조미료의 차이라고 할 수 있다.Refined salt is a common salt, and the difference between salt and salt is the difference between natural seasoning and chemical seasoning.
햇빛과 바닷물, 갯벌이라는 천혜의 자연조건을 이용해 만드는 천일염은 칼슘, 마그네슘, 아연 및 칼륨과 같은 미네랄이 풍부하지만, 정제염은 바닷물을 이온교환막에 전기 분해해서 염화나트륨을 얻은 뒤 불순물을 제거해서 만들기 때문에 미네랄이 함유되지 않은 99.8%의 고염도 소금이다.Sun-salt, sea water, and tidal flats, which are made with natural conditions, are rich in minerals such as calcium, magnesium, zinc and potassium. However, since purified water is electrolyzed in ion exchange membrane to obtain sodium chloride and remove impurities, Is 99.8% high salt salt not contained.
그러므로, 염화나트륨이 성분의 대부분을 차지하는 정제염보다는, 각종 미네랄이 풍부하고 나트륨의 함량이 상대적으로 적은 천일염이 건강에 더 유익하다고 할 수 있다.Therefore, it is more beneficial to health than salty salts, where sodium chloride accounts for most of the constituents, and a variety of minerals and sodium salts are relatively low.
천일염이나 정제염 외에 영양성분 또는 기능성을 강화한 다양한 종류의 가공소금이 시중에 유통되고 있다. 대표적으로 오래 전부터 식용으로 사용되고 있는 죽염을 들 수 있으며, 최근에는 레몬소금, 간장소금 등 소금에 여러 가지 재료를 혼합하여 섭취하는 방법도 활발히 연구되고 있다. In addition to sun saliva and tablets, various kinds of processed salt fortified with nutrients or functionalities are distributed on the market. Bamboo salt, which has been used for a long time as a typical example, can be mentioned. In recent years, a method of mixing various materials with salt such as lemon salt and soy sauce salt has been actively studied.
그러나 다른 재료를 소금에 혼합하는 경우, 소금 본연의 기능이 약화되거나, 심할 경우에는 인체에 좋지 않은 영향을 끼치는 소금이 얻어지기도 하므로, 위생적인 방법으로 충분한 시험을 통하여 제조할 필요가 있다. However, when other materials are mixed with salt, the function of the salt itself may be weakened or, in severe cases, salt may be obtained which adversely affects the human body. Therefore, it is necessary to prepare the material through a sufficient test in a hygienic manner.
본 발명은 천일염, 옥분말, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로부터 물을 증발시켜 얻는 미네랄을 포함하는 옥소금을 제공하는 것을 목적으로 한다.The object of the present invention is to provide jade salt, jade powder, and jade salt containing minerals obtained by evaporating water from natural alkali reduced water having a pH of 7.5 to 8.5, collected in the jade mine area.
또한, 본 발명은 상기 옥소금에 산야초 효소액을 부가한 옥소금을 제공하는 것을 목적으로 한다. It is another object of the present invention to provide an oxalate obtained by adding a solution of anthraquinone enzyme to the above oxalate.
상기 목적을 달성하기 위하여, 본 발명은,In order to achieve the above object,
천일염, 옥분말, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로부터 물을 증발시켜 얻는 미네랄을 포함하는 옥소금으로서,Oxalate containing minerals obtained by evaporation of water from natural alkaline-reduced water of pH 7.5 to 8.5, taken from the sun-salt, jade powder, and jade mine area,
(a) 천일염 30~55 중량부, 옥분말 1~5 중량부, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수 40~65 중량부를 혼합한 후, 850~1400℃로 가열하여 혼합 용융물을 제조하는 단계;(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a melt;
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화 하는 단계; 및(b) cooling the mixed melt produced in step (a) to solidify the mixed melt; And
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조된 것을 특징으로 하는 옥소금을 제공한다.(c) pulverizing the solid salt prepared in the step (b).
상기 옥소금은The oxalate
(d) 상기 (c)단계에서 제조된 옥소금에 산야초 효소액을 분무하여 건조시키는 단계; 및(d) spraying a solution of the crude yam salt with the crude yam powder prepared in step (c) and drying; And
(e) 상기 (d)단계에서 제조된 옥소금을 숙성시키는 단계;를 더 포함하여 제조되는 특징을 가질 수 있다. (e) aging the oxalate produced in the step (d).
또한, 상기 옥분말은 연옥분말일 수 있다.In addition, the jade powder may be a nephrite powder.
상기 산야초 효소액은The soybean enzyme solution
(ⅰ) 은행 1~20 중량%, 도라지 1~20 중량%, 참취 1~20 중량%, 참나물 1~20 중량%, 더덕 1~20 중량%, 움나무 1~20 중량%, 잔대 1~20 중량%, 산마늘 1~20 중량%, 및 할미꽃 1~20 중량%를 포함하는 산야초를 씻어 물을 빼는 단계;(I) 1 to 20% by weight of a bank, 1 to 20% by weight of a bellflower, 1 to 20% by weight of an aroma, 1 to 20% by weight of a crude oil, 1 to 20% 1 to 20% by weight of an acidic garlic, and 1 to 20% by weight of a hymenoptera;
(ⅱ) 상기 (ⅰ)단계에서 씻은 산야초를 항아리에 넣고, 미생물의 먹이가 될 수 있는 당을 상기 산야초 100 중량부를 기준으로 10~30 중량부로 넣어주는 단계;(Ii) adding the sanitary ware washed in step (i) into a jar and adding 10 to 30 parts by weight of sugar which can be a food for the microorganism based on 100 parts by weight of the sanayasia;
(ⅲ) 공기가 통할 수 있게 항아리를 봉하여 그늘에 보관하는 단계; 및(Iii) sealing the jar so that air can pass through and storing the jar in the shade; And
(ⅳ) 1~4개월 후에 발효된 찌꺼기를 걸러서 짜낸 후, 3~10개월 숙성시키는 단계;를 포함하는 방법에 의해 제조되는 특징을 가질 수 있다.(Iv) squeezing out the fermented residue after 1 to 4 months, and aging for 3 to 10 months.
또한, 본 발명은,Further, according to the present invention,
(a) 천일염 30~55 중량부, 옥분말 1~5 중량부, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수 40~65 중량부를 잘 혼합한 후, 850~1400℃로 가열하여 혼합 용융물을 제조하는 단계;(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a mixed melt;
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화시키는 단계; 및 (b) cooling and solidifying the mixed melt produced in the step (a); And
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조되는 것을 특징으로 하는 옥소금의 제조방법을 제공한다.and (c) pulverizing the solid salt produced in the step (b).
본 발명의 옥소금의 제조방법은The process for producing oxalate according to the present invention comprises
(d) 상기 (c)단계에서 제조된 분쇄 고체 소금에 산야초 효소액을 분무하여 건조시키는 단계; 및(d) spraying and drying a solution of the legume enzyme on the pulverized solid salt prepared in the step (c); And
(e) 상기 (d)단계에서 제조된 조성물을 숙성시키는 단계;를 포함하는 특징을 가질 수 있다.(e) aging the composition prepared in the step (d).
본 발명의 옥소금은 천일염, 옥분말, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로부터 물을 증발시켜 얻는 미네랄을 포함하함으로써, 역류성 식도염에 우수한 효과를 나타낸다. 또한, 위장 강화, 해독 강화, 백혈구 증가, 정혈, 소염, 체질개선, 입냄세 제거, 해열, 식욕 촉진 등에 우수한 효과를 나타낸다. The oxalate of the present invention exhibits an excellent effect on reflux esophagitis by containing minerals obtained by evaporation of water from sodium salt, jade powder, and natural alkaline-reduced water of pH 7.5 to 8.5 collected in the area of jade mine. It also has excellent effects on strengthening the stomach, strengthening the detoxification, increasing the leukocyte, blood circulation, inflammation, improving the constitution, eliminating the smell, fever and promoting appetite.
또한, 산야초 효소액을 더 포함하는 경우에는 더 강화된 효과를 제공한다. In addition, it further enhances the effect when it further comprises a solution of the genus Sanjay enzyme.
이하에서 본 발명의 바람직한 실시예를 첨부된 도면을 참고하여 설명한다. 본 발명의 상세한 설명에 앞서, 이하에서 설명되는 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 안 된다. 따라서, 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 일실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.Hereinafter, preferred embodiments of the present invention will be described with reference to the accompanying drawings. Prior to the description of the present invention, terms and words used in the present specification and claims to be described below should not be construed as limited to ordinary or dictionary terms. Therefore, the embodiments described in this specification and the configurations shown in the drawings are merely the most preferred embodiments of the present invention and do not represent all the technical ideas of the present invention. Therefore, It is to be understood that equivalents and modifications are possible.
본 발명은 천일염, 옥분말, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로부터 물을 증발시켜 얻는 미네랄을 포함하는 옥소금으로서,The present invention is an oxalate containing minerals obtained by evaporating water from natural alkaline-reduced water having a pH of 7.5 to 8.5,
(a) 천일염 30~55 중량부, 옥분말 1~5 중량부, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수 40~65 중량부를 혼합한 후, 850~1400℃로 가열하여 혼합 용융물을 제조하는 단계;(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a melt;
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화 하는 단계; 및(b) cooling the mixed melt produced in step (a) to solidify the mixed melt; And
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조된 것을 특징으로 하는 옥소금에 관한 것이다.(c) pulverizing the solid salt produced in the step (b).
상기 옥소금은The oxalate
(d) 상기 (c)단계에서 제조된 분쇄 고체 소금에 산야초 효소액을 분무하여 건조시키는 단계; 및(d) spraying and drying a solution of the legume enzyme on the pulverized solid salt prepared in the step (c); And
(e) 상기 (d)단계에서 제조된 조성물을 숙성시키는 단계;를 더 포함하여 제조된 것일 수 있다. (e) aging the composition prepared in the step (d).
본 발명의 옥소금은 역류성 식도염에 우수한 효과를 보인다. 또한, 하기와 같은 효능을 제공한다:The oxalate of the present invention shows an excellent effect on the reflux esophagitis. It also provides the following benefits:
1) 위장질환 개선1) Improvement of gastrointestinal diseases
옥소금은 건강의 근원인 위장을 튼튼히 하며 염증질환을 원인적으로 치료하는 약리작용을 제공한다. Jade salt strengthens the stomach, which is the source of health, and provides a pharmacological effect to cure inflammatory diseases.
2) 강한 해독작용2) strong detoxification action
옥소금은 우리 몸속에 생긴 독을 없애 준다. 옥소금의 강한 해독작용은 몸에 생긴 병독을 빠른 속도로 씻어 주어 여러 질환의 치료에 효과적이다(비염, 천식, 아토피 등 각종 알러지에도 좋다).Jade salt removes toxins from our bodies. The strong detoxifying action of the jade salt is effective for the treatment of various diseases by washing the body poisoning rapidly (it is good for various allergies such as rhinitis, asthma, atopy).
3) 백혈구 증강 및 병균 살균3) Leukocyte enhancement and sterilization of germs
옥소금은 병균을 잡아먹는 백혈구의 수를 증가시키고 살균력을 강화시키는 중요한 역할을 한다.Jade salt plays an important role in increasing the number of white blood cells consuming germs and enhancing bactericidal power.
4) 정혈작용4)
옥소금은 피를 맑게 하는 작용을 하므로 모든 병을 근원적으로 치료하고, 각종 성인병을 예방한다.Jade salt cleanses the blood, so it treats all diseases sickly and prevents various diseases.
5) 소염작용5) Anti-inflammatory action
옥소금은 염증을 제거하는데 탁월한 효능이 있다. 곪은 환부에 옥소금을 직접 뿌리면 염증이 낫게 된다.Jade salt has excellent efficacy in removing inflammation. Spread the jade salt directly on the affected area, the inflammation will be better.
6) 체질개선6) Improvement of constitution
옥소금은 산성체질을 약알칼리성 체질로 바꾸어 준다. 이 말은 곧 면역성과 저항력을 길러 주어 어떠한 병에도 끄떡없는 강인하고 단단한 체질을 갖게 한다. The jade salt turns the acidic constitution into a slightly alkaline constitution. These words soon develop immunity and resistance, which makes them stronger and more rigid than any disease.
7) 공기정화 및 악취제거7) Air purification and deodorization
옥소금은 사람에게는 약이 되나 해충에게는 독이 되기 때문에 구충제로도 사용된다. 각종 공해식품, 술, 담배, 약 등으로 체내에 노폐물이 쌓이게 되면 입과 몸에서 악취가 나게 되는데, 옥소금은 체내에 쌓인 노폐물을 제거하므로 문명병에 시달리는 현대인들에게 도움이 된다.Jade salt is also used as a pesticide because it is a medicine for humans, but poisonous for pests. Various pollution foods, alcohol, tobacco, medicine, etc., accumulate waste in the body, and odor comes from the mouth and body. It removes the waste accumulated in the body, so it helps modern people suffering from civilization.
8) 해열작용8)
균이 쌓여 염증이 생기면 열이 발생하는데 옥소금은 살균작용을 하므로 해열작용도 한다.When bacteria accumulate and inflammation occurs, heat is generated.
9) 식욕촉진9) Promotes appetite
옥소금은 위액의 원료인 위염산을 생산해 내어 음식물의 소화를 촉진시키므로 식욕을 개선한다.Jade salt produces stomach acid which is the raw material of stomach juice and improves appetite because it promotes digestion of food.
상기 옥분말로는 연옥분말이 바람직하게 사용될 수 있다. As the above-mentioned octane powder, a nephrite powder may be preferably used.
신농본초, 본초강목에 의하면 얼굴, 몸 등에 상처자국이 있을 때 연옥분말로 상처 부위를 수일간 문지르면 흉터가 없어지며 피부를 윤택하게 해주는 등 연옥의 주성분은 인체의 각 요소와 일치하여 부작용이 없이 인체에 탁월한 효능을 발휘하는 것으로 알려져 있다.When the wound is scratched for several days with a nephrite powder, the main component of the nephrite is consistent with each element of the body, such as scars disappear and the skin is enriched. Is known to exert excellent efficacy.
옥이 내는 원적외선은 인체의 혈액 순환을 왕성하게 하고 몸 속을 따뜻하게 열을 가해 주기 때문에 각종 성인병 예방에도 효과가 있다. 또한, 상기 원적외선은 치약 중의 다른 성분들의 활성을 극대화시키는 기능을 수행한다.The far-infrared rays inside the jade are effective for prevention of various adult diseases because the blood circulation of the body is energized and the heat is applied to the inside of the body. Further, the far-infrared rays function to maximize the activity of other components in the toothpaste.
동의보감에 의하면 옥가루를 깨알만하게 만들어 복용하면 오장육부를 윤택하게 하고 체내에 노폐물을 배출시켜 주며 위장의 열을 제거해 소화계통에 효과가 있으며, 또한 옥가루를 장복하면 몸이 날아갈 듯 가벼워지고 폐장의 기능을 윤활하게 해주며 성대의 발성을 도와주고 인후에 좋은 것으로 기술되어 있다. According to Donguibogam, it makes the corn germs softer and makes the corn germs more radiant, expels waste in the body, eliminates the heat of the stomach and is effective in the digestive system. Also, when the corn is ingested, it becomes lighter and easier. It lubricates, helps the voice of the vocal cords, and is described as good for the throat.
상기 연옥분말은 채광 시나 보석 세가공시에 파생되는 잔재 물 또는 폐기물로 처리되는 연옥을 사용하여 제조할 수 있어 바람직하다. It is preferable that the nephrite powder can be produced by using nephrite treated with remnants or wastes derived from mines or gemstones.
상기 연옥분말의 평균입자크기는 100 ∼ 300 메쉬인 것이 사용될 수 있다. The average particle size of the nephrite powder may be 100 to 300 mesh.
본 발명의 옥소금은 상기 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수(일명, '옥정수')를 사용하여 제조되는 것을 특징을 갖는다. 즉, 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수를 첨가하고 순수 물 성분을 모두 증발시킴으로써 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수에 포함된 무기질 및 미네랄 등의 유익한 성분이 제조되는 옥소금에 모두 포함될 수 있게 하는 특징을 갖는다. The oxalate of the present invention is characterized in that it is prepared using a natural alkali reduced water (aka, 'oak water') having a pH of 7.5 to 8.5, which is collected in the above mine area. In other words, by adding the natural alkaline reducing water of pH 7.5 ~ 8.5 collected in the jade mine area and evaporating all pure water components, beneficial components such as minerals and minerals contained in the natural alkaline reducing water of pH 7.5-8.5 Can be included in all of the oxalates to be produced.
옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로는 옥광산 지역에서 생산되는 지하수가 사용될 수 있다. 상기 옥광산 지역에서 생산되는 지하수는 물의 성질이 온순하고 맛이 달며 깨끗해서 독이 없는 특징을 갖는다(동의보감). 또한, 사람들이 오랫동안 먹으면 오장육부가 윤택해지고 체내의 노폐물이 빠져나가며, 머리털이 희어지지 않는다고 한다(본초강목). 중국 사람들은 예로부터 옥을 귀하게 여겨 늘 몸에 지지고 다니는 것으로 알려졌는데, 이는 인체에 직접적인 영향을 미쳐서 신경을 안정시키고 오장육부의 기능 강화에 효과가 있기 때문이라고 한다. Groundwater produced in the Jade Mine area can be used as the natural alkaline water of pH 7.5 ~ 8.5 collected from the Jade mine area. The groundwater produced in the Jade Mine area is characterized by the mild nature of the water, its taste, and its clean nature. In addition, when people eat for a long time, the five-legged meat becomes rich, the waste in the body escapes, and the hair is not whitened. It is said that Chinese people have always been prone to jade because they have been directly influenced by the human body, stabilizing the nervous system and strengthening the functions of the five muscles.
천연 알칼리환원수는 전세계적으로 희귀한 물로 학계에 조차 잘 알려져 있지 않은 물이다. 국내 혹은 일본에서도 알칼리환원수라 하면 보통 이온수기를 통해 만들어진 알칼리수로 구분한다. 알칼리수는 만성설사, 위염, 위산과다, 소화불량, 위장내 이상발효, 변비, 피로감해소, 감기예방, 식욕부진 회복, 고혈압, 당뇨, 알레르기, 류머티즘, 과음숙취해소, 천식, 두드러기에 효과가 있다.Natural Alkali Reduced Water is water that is rarely known even in academia because it is rare in the world. In Korea or Japan, alkaline water is usually divided into alkaline water, which is produced by ionized water. Alkaline water is effective in chronic diarrhea, gastritis, gastric hyperplasia, dyspepsia, abnormal gastric fermentation, constipation, relieving fatigue, preventing colds, restoring appetite, hypertension, diabetes, allergies, rheumatism, relieving hangover, asthma and urticaria.
본 발명의 옥소금의 제조에는 상기 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수가 사용되는 것이 가장 바람직하다. 그러나, 천연 pH 7.5~8.5의 천연 알칼리환원수라면 본 발명에 사용될 수도 있다. Most preferred is the use of the natural alkaline-reduced water of pH 7.5-8.5 taken from the above-mentioned jade mine area for the production of the jade salt of the present invention. However, natural alkaline reducing water having a natural pH of 7.5 to 8.5 may be used in the present invention.
상기에서 천연 알칼리환원수는 pH가 8.0~8.5인 것이 더욱 바람직하다.The pH of the natural alkali reduced water is more preferably 8.0 to 8.5.
상기 산야초 효소액은The soybean enzyme solution
(ⅰ) 은행 1~20 중량%, 도라지 1~20 중량%, 참취 1~20 중량%, 참나물 1~20 중량%, 더덕 1~20 중량%, 움나무 1~20 중량%, 잔대 1~20 중량%, 산마늘 1~20 중량%, 및 할미꽃 1~20 중량%를 포함하는 산야초를 씻어 물을 빼는 단계;(I) 1 to 20% by weight of a bank, 1 to 20% by weight of a bellflower, 1 to 20% by weight of an aroma, 1 to 20% by weight of a crude oil, 1 to 20% 1 to 20% by weight of an acidic garlic, and 1 to 20% by weight of a hymenoptera;
(ⅱ) 상기 (ⅰ)단계에서 씻은 산야초를 항아리에 넣고, 미생물의 먹이가 될 수 있는 당을 상기 산야초 100 중량부를 기준으로 10~30 중량부로 넣어주는 단계;(Ii) adding the sanitary ware washed in step (i) into a jar and adding 10 to 30 parts by weight of sugar which can be a food for the microorganism based on 100 parts by weight of the sanayasia;
(ⅲ) 공기가 통할 수 있게 항아리를 봉하여 그늘에 보관하는 단계; 및(Iii) sealing the jar so that air can pass through and storing the jar in the shade; And
(ⅳ) 1~4개월 후에 발효된 찌꺼기를 걸러서 짜낸 후, 3~10개월 숙성시키는 단계;를 포함하는 방법에 의해 제조될 수 있다. (Iv) squeezing out the fermented fermented product after 1 to 4 months, and aging for 3 to 10 months.
상기에서 당으로는 벌꿀과 설탕을 1~3 : 1~3 중량비로 혼합한 것이 사용될 수 있다.The saccharide may be a mixture of honey and sugar at a weight ratio of 1: 3: 1 ~ 3.
상기 산야초는 차곡차곡 눌러 담는 것이 바람직하며, 2주~6주 마다 거꾸로 한번 뒤집어 주는 것이 바람직하다. It is preferable that the artillery yam is pushed back and forth, and it is preferable to invert the artillery yam once every 2 to 6 weeks.
상기 방법에서는 별도의 미생물을 넣어주지 않았지만, 상기 (ⅱ)단계에서 이 분야에서 사용되는 공지의 미생물을 넣어 줄 수도 있다.Although no separate microorganism is added in the above method, known microorganisms used in this field may be added in the step (ii).
상기 식물 발효 효소액은 상기 (d)단계의 분쇄 고체 조성물 총 중량에 대하여 2~15 중량%의 양으로 분무될 수 있다.The plant fermentation enzyme solution may be sprayed in an amount of 2 to 15% by weight based on the total weight of the pulverized solid composition in the step (d).
본 발명의 옥소금은 건강기능성식품 조성물일 수 있다. 상기 옥소금은 그 자체로 건강기능식품 조성물로 사용될 수 있으며, 담체, 부형제 또는 희석제 등을 더 추가하여 다양한 형태로 제조될 수 있다. 상기 담체, 부형제 및 희석제로는 결정포도당, 트레할로스, 잔탄검, 아라비아검, 구아검, 탈지분유, 말토덱스트린, 젤라틴, 락토오스, 덱스트로오스, 수크로오스, 소르비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 칼슘 포스페이트, 칼슘실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 들 수 있다.The oxalate of the present invention may be a health functional food composition. The oxalate itself can be used as a health functional food composition, and can be prepared in various forms by further adding a carrier, an excipient, or a diluent. Examples of the carrier, excipient and diluent include crystalline glucose, trehalose, xanthan gum, gum arabic, guar gum, skim milk powder, maltodextrin, gelatin, lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, The present invention relates to a method for producing a microcapsule comprising a microcapsule containing at least one selected from the group consisting of acacia rubber, alginate, calcium phosphate, calcium silicate, cellulose, methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, .
상기 건강기능식품 조성물은 산제, 과립제, 환제 정제, 캡슐제, 현탁액, 에멀젼, 시럽제, 액제, 엑스제, 차, 젤리, 에어로졸, 음료 등의 형태로 제형화할 수 있다. The health functional food composition may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, solutions, expansions, tea, jellies, aerosols, drinks and the like.
상기 건강기능식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. The health functional food composition may contain various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and heavies (cheese, chocolate etc.), pectic acid and its salts, alginic acid and its salts , Organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like.
본 발명은 또한,The present invention also relates to
(a) 천일염 30~55 중량부, 옥분말 1~5 중량부, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수 40~65 중량부를 잘 혼합한 후, 850~1400℃로 가열하여 혼합 용융물을 제조하는 단계;(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a mixed melt;
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화시키는 단계; 및 (b) cooling and solidifying the mixed melt produced in the step (a); And
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조되는 것을 특징으로 하는 옥소금의 제조방법에 관한 것이다. and (c) pulverizing the solid salt prepared in the step (b).
상기 옥소금의 제조방법은 The production method of the above oxalate
(d) 상기 (c)단계에서 제조된 분쇄 고체 소금에 산야초 효소액을 분무하여 건조시키는 단계; 및(d) spraying and drying a solution of the legume enzyme on the pulverized solid salt prepared in the step (c); And
(e) 상기 (d)단계에서 제조된 조성물을 숙성시키는 단계;를 더 포함할 수 있다. (e) aging the composition prepared in step (d).
상기 옥소금에서 전술된 내용은 모두 상기 제조방법에 적용될 수 있다. 그러므로 중복된 내용은 생략한다.All of the above-mentioned contents of the above-mentioned oxalate can be applied to the above-mentioned production method. Therefore, duplicate content is omitted.
본 발명의 옥소금의 복용량은 특별히 한정되지 않으나, 하루 복용량이 50g을 초과하지 않는 것이 바람직하며, 1회에 1~5g 씩을 물 없이 또는 물과 함께 자주 복용하는 것이 바람직하다.The dose of the oxazatol of the present invention is not particularly limited, but it is preferable that the daily dose does not exceed 50 g, and it is preferable to take 1 to 5 g at a time frequently without water or with water frequently.
이하, 본 발명을 실시예를 들어 더욱 상세히 설명하지만, 본 발명이 하기 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited to the following examples.
제조예Manufacturing example 1: 산야초 1: Sanayachi 효소액의Enzyme solution 제조 Produce
은행 10 중량%, 도라지 20 중량%, 참취 10 중량%, 참나물 10 중량%, 더덕 10 중량%, 움나무 10 중량%, 잔대 10 중량%, 산마늘 10 중량%, 및 할미꽃 10 중량%를 물로 씻어 물을 완전히 뺐다.10 wt.% Of bank, 10 wt.% Of anchovy, 10 wt.% Of sea tangle, 10 wt.% Of dodeca, 10 wt.% Of mulberry, 10 wt. I completely removed the water.
상기에서 씻은 산야초를 건조된 항아리에 넣고, 미생물의 먹이가 될 수 있는 당으로서 벌꿀과 흑설탕을 1:1의 중량비로 상기 산야초 100 중량부를 기준으로 20 중량부를 넣어주었다. 그 다음 공기가 통할 수 있게 항아리를 봉하여 그늘에 보관하였다. 1개월에 1회씩 산야초를 뒤집에 주면서 3개월 동안 발효시켰다. 그 다음 발효된 찌꺼기를 걸러서 짜낸 후, 9개월간 더 숙성시켜서 산야초 효소액을 제조하였다. The washed yamatsu yamatsu were placed in a dried jar and 20 parts by weight of honey and brown sugar as a sugar which can be fed to microorganisms were added at a weight ratio of 1: 1 based on 100 parts by weight of the yamatsuya. Then the jar was sealed to allow air to pass through and stored in the shade. It was fermented for 3 months while giving back to the farmland once a month. Then, the fermented residue was squeezed out and squeezed for 9 months to prepare a solution of Sanjayo enzyme.
실시예Example 1: One: 옥소금Jade salt
천일염 5 kg에 평균입자크기가 200메쉬인 연옥분말 150 g 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로서 대일광업㈜ 제조"옥산가"5 리터를 넣고, 잘 혼합하였다. 다음 가마솥을 850~900℃로 가열하여 혼합 용융물을 제조한 후, 냉각시켜서 고체화시켰다. 상기에서 제조된 고체 조성물을 분쇄하여 옥소금을 제조하였다.150 g of nephrite powder having an average particle size of 200 mesh in 5 kg of sun salts and 5 liters of natural alkaline reducing water of pH 7.5-8.5, manufactured by Daeil Mining Co., Ltd., were taken and mixed well. Next, the cauldron was heated to 850 to 900 DEG C to prepare a mixed melt, followed by cooling and solidification. The solid composition prepared above was ground to produce oxalate.
실시예Example 2: 2: 옥소금Jade salt (산야초 (Sanayachi 효소액Enzyme solution 첨가) adding)
천일염 5 kg에 평균입자크기가 200메쉬인 연옥분말 150 g 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수로서 대일광업㈜ 제조"옥산가"5 리터를 넣고, 잘 혼합하였다. 다음 가마솥을 850~900℃로 가열하여 혼합 용융물을 제조한 후, 냉각시켜서 고체화시켰다. 상기에서 제조된 고체 조성물을 분쇄한 후, 상기 분쇄 고체 조성물에 상기 제조예 1에서 제조된 산야초 효소액 500 ml를 분무하고 건조시켰다. 다음에 상기 건조된 분쇄 고체 조성물을 직사광선이 없는 곳에서 3개월 간 숙성시켜서 옥소금을 제조하였다. 150 g of nephrite powder having an average particle size of 200 mesh in 5 kg of sun salts and 5 liters of natural alkaline reducing water of pH 7.5-8.5, manufactured by Daeil Mining Co., Ltd., were taken and mixed well. Next, the cauldron was heated to 850 to 900 DEG C to prepare a mixed melt, followed by cooling and solidification. After the solid composition prepared above was pulverized, 500 ml of the crude oil solution prepared in Preparation Example 1 was sprayed on the pulverized solid composition and dried. Next, the dried pulverized solid composition was aged for three months in the absence of direct sunlight to produce oxalate.
시험예Test Example : : 옥소금의Jade 효과 평가 Effect evaluation
역류성 식도염 증상이 있는 성인 남자 10명 여자 10명을 피험군으로 하여 상기 실시예 1 및 2에서 제조된 옥소금을 1일 5회 1회당 1.5g씩 2~3 시간 간격으로 복용하게 하고, 복용후 10일, 20일, 30일에 역류성 식도염의 개선 정도를 평가하고, 그 결과를 하기 표 1에 나타내었다. 대조군으로는 역류성 식도염 증상이 있는 성인 남자 1명 및 여자 1명에게 죽염을 상기와 동일한 방법으로 복용하게 하고, 개선정도를 평가하였다.10 male and 10 female subjects with symptoms of reflux esophagitis were selected as the experimental group. The oxalate prepared in Examples 1 and 2 was administered at intervals of 2 to 3 hours with 1.5 g / The degree of improvement of reflux esophagitis was evaluated on days 10, 20, and 30, and the results are shown in Table 1 below. As a control group, one adult male and one female with symptoms of reflux esophagitis were treated with bamboo salt in the same manner as above, and the degree of improvement was evaluated.
<평가기준><Evaluation Criteria>
◎: 80% 개선됨◎: 80% improved
○: 50% 개선됨○: 50% improved
△: 20% 개선됨△: 20% improvement
×: 변화 없음X: No change
××: 악화됨××: worse
상기 표 1의 결과로부터 본 발명의 옥소금을 복용한 피혐군들의 경우, 죽염만 복용한 대조군들보다 명백히 우수한 역류성 식도염 개선효과를 얻은 것으로 확인되었다. 또한, 부작용은 전혀 확인되지 않았다.From the results shown in the above Table 1, it was confirmed that the subjects receiving the oxalate according to the present invention had significantly improved reflux esophagitis than the control subjects taking bamboo salt only. No side effects were observed at all.
Claims (6)
(a) 천일염 30~55 중량부, 옥분말 1~5 중량부, 및 옥광산 지역에서 채취한 pH 7.5~8.5의 천연 알칼리환원수 40~65 중량부를 혼합한 후, 850~1400℃로 가열하여 혼합 용융물을 제조하는 단계;
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화 하는 단계; 및
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조된 것을 특징으로 하는 옥소금.Oxalate containing minerals obtained by evaporation of water from natural alkaline-reduced water of pH 7.5 to 8.5, taken from the sun-salt, jade powder, and jade mine area,
(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a melt;
(b) cooling the mixed melt produced in step (a) to solidify the mixed melt; And
(c) pulverizing the solid salt prepared in the step (b).
(d) 상기 (c)단계에서 제조된 옥소금에 산야초 효소액을 분무하여 건조시키는 단계; 및
(e) 상기 (d)단계에서 제조된 옥소금을 숙성시키는 단계;를 더 포함하여 제조된 것임을 특징으로 하는 옥소금.The method according to claim 1,
(d) spraying a solution of the crude yam salt with the crude yam powder prepared in step (c) and drying; And
(e) aging the oxalate prepared in the step (d).
상기 옥분말은 연옥분말인 것을 특징으로 하는 옥소금.The method according to claim 1,
Wherein the jade powder is a nephrite powder.
상기 산야초 효소액은
(ⅰ) 은행 1~20 중량%, 도라지 1~20 중량%, 참취 1~20 중량%, 참나물 1~20 중량%, 더덕 1~20 중량%, 움나무 1~20 중량%, 잔대 1~20 중량%, 산마늘 1~20 중량%, 및 할미꽃 1~20 중량%를 포함하는 산야초를 씻어 물을 빼는 단계;
(ⅱ) 상기 (ⅰ)단계에서 씻은 산야초를 항아리에 넣고, 미생물의 먹이가 될 수 있는 당을 상기 산야초 100 중량부를 기준으로 10~30 중량부로 넣어주는 단계;
(ⅲ) 공기가 통할 수 있게 항아리를 봉하여 그늘에 보관하는 단계; 및
(ⅳ) 1~4개월 후에 발효된 찌꺼기를 걸러서 짜낸 후, 3~10개월 숙성시키는 단계;를 포함하는 방법에 의해 제조되는 것임을 특징으로 하는 옥소금.The method of claim 2,
The soybean enzyme solution
(I) 1 to 20% by weight of a bank, 1 to 20% by weight of a bellflower, 1 to 20% by weight of an aroma, 1 to 20% by weight of a crude oil, 1 to 20% 1 to 20% by weight of an acidic garlic, and 1 to 20% by weight of a hymenoptera;
(Ii) adding the sanitary ware washed in step (i) into a jar and adding 10 to 30 parts by weight of sugar which can be a food for the microorganism based on 100 parts by weight of the sanayasia;
(Iii) sealing the jar so that air can pass through and storing the jar in the shade; And
(Iv) squeezing out the fermented fermented product after 1 to 4 months, and aging the product for 3 to 10 months.
(b) 상기 (a)단계에서 제조된 혼합 용융물을 냉각시켜 고체화시키는 단계; 및
(c) 상기 (b)단계에서 제조된 고체 소금을 분쇄하는 단계;를 포함하여 제조되는 것을 특징으로 하는 옥소금의 제조방법.(a) 30 to 55 parts by weight of a salt of austenite, 1 to 5 parts by weight of a jade powder, and 40 to 65 parts by weight of a natural alkali-reduced water having a pH of 7.5 to 8.5, Producing a mixed melt;
(b) cooling and solidifying the mixed melt produced in the step (a); And
(c) pulverizing the solid salt produced in the step (b).
(d) 상기 (c)단계에서 제조된 분쇄 고체 소금에 산야초 효소액을 분무하여 건조시키는 단계; 및
(e) 상기 (d)단계에서 제조된 조성물을 숙성시키는 단계;를 포함하는 것을 특징으로 하는 옥소금의 제조방법.
The method of claim 5,
(d) spraying and drying a solution of the legume enzyme on the pulverized solid salt prepared in the step (c); And
(e) aging the composition prepared in the step (d).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170100925A KR102081672B1 (en) | 2017-08-09 | 2017-08-09 | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170100925A KR102081672B1 (en) | 2017-08-09 | 2017-08-09 | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190016688A true KR20190016688A (en) | 2019-02-19 |
KR102081672B1 KR102081672B1 (en) | 2020-02-26 |
Family
ID=65528695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170100925A KR102081672B1 (en) | 2017-08-09 | 2017-08-09 | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102081672B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102642748B1 (en) | 2021-11-24 | 2024-03-04 | 최미경 | Shampoo composition for improving scalp and hair health |
KR20230119798A (en) | 2022-02-08 | 2023-08-16 | 최미경 | Cleansing foam containing jade enzyme salt |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010066711A (en) * | 1999-12-31 | 2001-07-11 | 김원배 | Bamboo Salt Using Veinstone |
KR20030096208A (en) * | 2003-12-03 | 2003-12-24 | 최승우 | Production of functional salt using herbal extract and sea salt |
KR20170026850A (en) | 2015-08-31 | 2017-03-09 | 농업회사법인 주식회사 백산 | Manufacturing method of roasted salicomia herbaceal salt coated with salicomia herbaceal extract and the roasted salicomia herbaceal salt made by the method |
KR101808328B1 (en) * | 2017-06-20 | 2017-12-13 | 주식회사 성민코리아 | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same |
-
2017
- 2017-08-09 KR KR1020170100925A patent/KR102081672B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010066711A (en) * | 1999-12-31 | 2001-07-11 | 김원배 | Bamboo Salt Using Veinstone |
KR20030096208A (en) * | 2003-12-03 | 2003-12-24 | 최승우 | Production of functional salt using herbal extract and sea salt |
KR20170026850A (en) | 2015-08-31 | 2017-03-09 | 농업회사법인 주식회사 백산 | Manufacturing method of roasted salicomia herbaceal salt coated with salicomia herbaceal extract and the roasted salicomia herbaceal salt made by the method |
KR101808328B1 (en) * | 2017-06-20 | 2017-12-13 | 주식회사 성민코리아 | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
KR102081672B1 (en) | 2020-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100941160B1 (en) | Preparation of fermented rice punch | |
KR101541516B1 (en) | Mathod Manufacturing lON Mineral Using Silk worm, Muberry leaf, and Muberry twig And Health Drink Manufactured by this | |
KR100893350B1 (en) | Method for producing the fermented liquid and powder extracted from macrophytes | |
KR101158448B1 (en) | The producing process of functional and fermented material containing high-concentration GABA by fermentation with yeast extract | |
CN102599589B (en) | Method for preparing Noni fruit juice by fermentation method | |
KR101018065B1 (en) | Method for manufacturing health drink using jujube leaf and health drink manufactured by this | |
CN101716007A (en) | Cassia bark and ginger health-care beverage and preparation method thereof | |
KR102332053B1 (en) | Method for producing functional salt | |
CN102860549B (en) | Functional beverage having functions of beautifying and detoxification and preparation method thereof | |
KR100975669B1 (en) | Method for manufacturing rice wine and distilled wine | |
KR101025286B1 (en) | Method for Preparing Functional Natural Fermentation Condiment and Sea-Tangle Fermentation Powder Containing GABA Using Fermentation of Sea-Tangle | |
KR20190016688A (en) | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same | |
CN101380128B (en) | Zhukui multifunctional health care beverage and production method thereof | |
CN110710626A (en) | Tremella and bird's nest composite suspension beverage and preparation method thereof | |
KR101808328B1 (en) | Composition for improvement and prevention of gastroesophageal reflux disease and method for preparing the same | |
KR102197395B1 (en) | The process of making healthcare composition for relieving and preventing alcoholic hangover comprising fermented Dendropanax morbifera extract and Capsosiphon fulvescens extracts | |
KR20100114974A (en) | A functional beverage comprising deep sea water, extract of black garlic, extract of jujubae fructus and organic acid | |
CN110663955A (en) | Composition for resisting saccharification and preventing aging and preparation method thereof | |
CN105325823A (en) | Kwas chlebowy drink and preparation method thereof | |
CN105231227A (en) | Production method of fructus cannabis and corn milk | |
KR20150025861A (en) | Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof | |
KR101852313B1 (en) | mushroom extract containing mushroom active ingredient manufacturing method and Kimchi containing mushroom extract | |
CN106937718A (en) | A kind of pair of marine alga pollen plant composite beverage and preparation method thereof | |
KR100936455B1 (en) | Mnufacturing method with pira cocos wolf for drink | |
KR20210114674A (en) | Manufacturing method of grub granule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |